Text Size

Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting

This study is currently recruiting participants.
Verified January 2012 by VU University of Amsterdam
Sponsor:
Information provided by (Responsible Party):
Paul M.G.Emmelkamp, VU University of Amsterdam
ClinicalTrials.gov Identifier:
NCT00847548
First received: February 18, 2009
Last updated: January 22, 2012
Last verified: January 2012
History of Changes
  Purpose

Intimate partner violence is a significant societal problem. However, treatment of IPV perpetrators is far from effective, which may be partly due to the fact that the role of substance abuse is not taken into account. There is considerable evidence that a strong relationship between the use of alcohol and other drugs and intimate partner violence exists. Besides, a few studies indicate that reducing substance use may have a positive impact on IPV. Therefore, in this study, perpetrators of intimate partner violence with substance use disorders enrolled in domestic violence treatment will be randomly assigned to either standard treatment for offenders of domestic violence or a combination of the latter treatment with cognitive-behavioral therapy addressing substance abuse (combined treatment).


Condition Intervention
Domestic Violence
Substance Abuse
 Behavioral: substance abuse/domestic violence treatment
Behavioral: CBT addression paertner violence

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by VU University of Amsterdam:

Primary Outcome Measures:
  • Quick Drinking Screen (QDS) [ Time Frame: pretest, posttest, 6 & 12 months follow-up ] [ Designated as safety issue: No ]
  • Conflict Tactics Scale (CTS) [ Time Frame: pretest, halfway treatment, posttest, 6 & 12 months follow-up ] [ Designated as safety issue: No ]
  • Timeline Followback interview [ Time Frame: pretest, posttest ] [ Designated as safety issue: No ]
    Assesses daily substance use in the past 4 months


Secondary Outcome Measures:
  • Brief Symptom Inventory (BSI) [ Time Frame: pretest, posttest, 6 and 12 moths follow-up ] [ Designated as safety issue: No ]
    Assesses general psychological complaints

  • Maudsly Marital Questionnaire (MMQ) [ Time Frame: pretest, posttest, 6 and 12 months follow up ] [ Designated as safety issue: No ]
    Assesses marital satisfaction


Estimated Enrollment: 100
Study Start Date: February 2009
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: combined treatment
A combined treatment containing cognitive behavioral therapy addressing partner violence and cognitive behavioral therapy addressing substance abuse
 Behavioral: substance abuse/domestic violence treatment
This intervention is comprised of 16 sessions of cognitive behavioral therapy. 8 sessions are addressing partner violence and 8 sessions are addressing substance abuse
Active Comparator: control condition
Cognitive behavioral therapy addressing partner violence
 Behavioral: CBT addression paertner violence
This treatment is comprised of 16 sessions of cognitive behavioral therapy addressing partner violence.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • A history of perpatration of intimate partner violence
  • Alcohol, cannabis and/or cocaine abuse or dependence

Exclusion Criteria:

  • Not sufficient fluency in Dutch to complete treatment and measures
  • (ab)use of crack cocaine and/or heroin
  • Psychosis
  • Psychopathy
  • Couples therapy more indicated
  • Abuse of children
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00847548

Contacts
Contact: Fleur L. Kraanen, MSc. +31 20 525 6728 ext 6728 F.L.Kraanen@uva.nl
Contact: Paul M.G. Emmelkamp, PhD. +31 20 525 6718 ext 6718 P.M.G.Emmelkamp@uva.nl

Locations
Netherlands
De Waag Amsterdam & Rijnmond Recruiting
Amsterdam / Rotterdam, Netherlands, 1018AJ
Sponsors and Collaborators
VU University of Amsterdam
Investigators
Principal Investigator: Paul M.G. Emmelkamp, PhD. VU University of Amsterdam
  More Information

No publications provided

Responsible Party: Paul M.G.Emmelkamp, Prof. Dr. P.M.G. Emmelkamp, VU University of Amsterdam
ClinicalTrials.gov Identifier: NCT00847548     History of Changes
Other Study ID Numbers: 2008-KP-463
Study First Received: February 18, 2009
Last Updated: January 22, 2012
Health Authority: Netherlands: Independent Ethics Committee

Keywords provided by VU University of Amsterdam:
intimate partner violence
domestic violence
substance abuse
 alcohol abuse
drug abuse
addiction

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on September 26, 2012